Author: Nagaya Noritoshi
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.4, Iss.2, 2004-01, pp. : 75-85
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry, Vol. 14, Iss. 6, 2007-03 ,pp. :
Treatment of Primary Pulmonary Hypertension
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 3, 2002-09 ,pp. :
Medical management of primary pulmonary hypertension
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. :
Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. :
Inhaled Iloprost: In Primary Pulmonary Hypertension
By Goldsmith D.R. Wagstaff A.J.
Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. :